Pembrolizumab and SBRT in Metastatic Non-small-cell Lung Cancer Patients

Conditions:   Non Small Cell Lung Cancer;   NSCLC;   NSCLC, Stage IIIB;   NSCLC Stage IV Interventions:   Drug: Pembrolizumab;   Radiation: Sterotactic Body Radiotherapy Sponsors:   Royal Marsden NHS Foundation Trust;   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials